Upgrade to SI Premium - Free Trial

Leerink Partners on CVS Health (CVS): potential settlement removes uncertainty clouding PBM biz

March 24, 2026 2:55 PM
Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $98.00 price target on CVS Health (NYSE: CVS)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments